Denosumab: Uses, Mechanism & Side Effects
Denosumab is a monoclonal antibody used to treat osteoporosis and bone-related cancer complications. It inhibits bone resorption and helps increase bone density.
Things worth knowing about "Denosumab"
Denosumab is a monoclonal antibody used to treat osteoporosis and bone-related cancer complications. It inhibits bone resorption and helps increase bone density.
What is Denosumab?
Denosumab is a fully human monoclonal antibody that specifically targets the RANK ligand (RANKL), a key signaling protein involved in bone resorption. It is produced using biotechnology and is available under two brand names: Prolia® for the treatment of osteoporosis, and Xgeva® for the prevention of skeletal-related complications in cancer patients with bone metastases.
Mechanism of Action
Bone tissue is continuously broken down and rebuilt in a process called bone remodeling. The breakdown is carried out by specialized cells known as osteoclasts, which are activated by RANKL. Denosumab binds with high affinity to RANKL, blocking its interaction with its receptor RANK on the surface of osteoclast precursor cells. This inhibits the formation, activation, and survival of osteoclasts, resulting in significantly reduced bone resorption and an increase in bone mineral density (BMD).
Indications
- Postmenopausal osteoporosis: To reduce the risk of fractures in women after menopause.
- Osteoporosis in men: To reduce fracture risk in male patients with osteoporosis.
- Hormone therapy-induced bone loss: In men with prostate cancer receiving androgen deprivation therapy and in women with breast cancer on aromatase inhibitor therapy.
- Bone metastases: Xgeva® is used to delay skeletal-related events such as fractures and bone pain in patients with solid tumors.
- Giant cell tumor of bone: In unresectable or recurrent cases.
Dosage and Administration
Denosumab is administered as a subcutaneous injection (under the skin), typically in the abdomen, upper thigh, or upper arm.
- Prolia®: 60 mg every 6 months.
- Xgeva®: 120 mg every 4 weeks (for bone metastases or giant cell tumor).
Treatment should only be administered under medical supervision. Adequate calcium and vitamin D supplementation is recommended unless contraindicated.
Side Effects
Like all medications, denosumab can cause side effects. Common ones include:
- Pain in the arms and legs (musculoskeletal pain)
- Muscle weakness and aches
- Low blood calcium levels (hypocalcemia) – particularly in patients with kidney impairment
- Urinary tract or respiratory infections
Rare but serious side effects include:
- Osteonecrosis of the jaw (ONJ): Bone tissue death in the jaw, especially following dental procedures.
- Atypical femoral fractures: Stress fractures of the thigh bone with long-term use.
- Rebound effect: After discontinuation of denosumab, a rapid increase in bone resorption may occur. Transition to bisphosphonate therapy is therefore recommended to prevent this effect.
Contraindications and Precautions
- Hypocalcemia must be corrected before starting therapy.
- Patients with severe renal impairment are at higher risk of hypocalcemia and require close monitoring.
- Denosumab must not be used during pregnancy.
- Patients should consult their physician before any planned dental procedures.
References
- European Medicines Agency (EMA): Prolia (Denosumab) – Summary of Product Characteristics and Assessment Report. https://www.ema.europa.eu
- Cummings SR et al. – Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis. New England Journal of Medicine, 2009; 361(8):756–765.
- Bone HG et al. – 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. The Lancet Diabetes & Endocrinology, 2017; 5(7):513–523.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryAlveolar ridge augmentation
Bone resorption markers
Maxillary fracture
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Denosumab